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Abstract: Quantitative autoradiography of [3H]MK-80 1 
binding was used to characterize regional differences in N- 
methyl-D-aspartate (NMDA) receptor pharmacology in rat 
CNS. Regionally distinct populations of NMDA receptors 
were distinguished on the basis of regulation of [3H]MK- 
80 1 binding by the NMDA antagonist 3-(2-carboxypipera- 
zin-4-yl)-propyl- 1 -phosphonic acid (CPP). CPP inhibited 
[3H]MK-801 binding in outer cortex (OC) and medial cor- 
tex (MC) with apparent Ki values of 0.32-0.48 pM, whereas 
in the medial striatum (MS), lateral striaturn (LS), CAI, and 
dentate gyrus (DG) of hippocampus, apparent K, values 
were 1.1 - 1.6 pA4. In medial thalamus (MT) and lateral thala- 
mus (LT) the apparent K, values were 0.78 pM. In the pres- 
ence of added glutamate (3 pM),  the relative differences in 
apparent Ki values between regions maintained a similar 
relationship with the exception ofthe OC. Inhibition of [3H]- 
MK-80 1 binding by the glycine site antagonist 7-chlorokyn- 
urenic acid (7-C1K:yn) distinguished at least two populations 
of NMDA receptors that differed from populations defined 
by CPP displacement. 7-CIKyn inhibited [3H]MK-80 1 bind- 
ing in OC, MC, NS, and LS with apparent Ki values of 
6.3-8.6 pM, whereas in CAI, DG, LT, and MT, Ki values 
were 1 1.4-13.6 pM. In the presence of added glycine (1 
pM) ,  the relative differences in apparent Ki values were 
maintained. Under conditions of differential receptor acti- 
vation, regional difyerences in NMDA receptor pharmacol- 
ogy can be detected using [3H]MK-801 binding. Key 
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Excitatory amino acids such as glutamate or aspar- 
tate are the predominant neurotransmitters mediat- 
ing excitatory synaptic transmission at a majority of 
synapses in mammalian CNS. Based on electrophysio- 
logical and biochemical studies, excitatory amino 
acid receptors have been divided into the follow- 
ing scheme: N-methy baspartate (NMDA) recep- 
tors, (R,S)-a-amino-3-hydroxy-5-methyl-4-isoxazole- 
propionic acid receptors, kainate receptors, and me- 
tabotropic receptors linked to phosphoinositide 
turnover (Dingledine et al., 1988; Monaghan et al., 
1989; Young and Fagg, 1990). 
The NMDA receptor is found throughout the 
mammalian CNS and is involved in both physiologi- 
cal and pathophysiological processes. Activation of 
the NMDA receptor is believed to play a role in the 
establishment of long-term potentiation, learning, 
memory, synaptic plasticity, and development (Col- 
lingridge and Bliss, 1987; Cotman and Iversen, 1987; 
Collingridge and Singer, 1990). Overactivation of 
NMDA receptors is thought to contribute to neuronal 
damage in epilepsy, hypoxia-ischemia, and neurode- 
generative disorders (Maragos et al., 1987; Rothman 
and Olney, 1987; Choi, 1988; Greenamyre and 
Young, 1990). 
The NMDA receptor is a ligand-gated ion channel 
that is gated by magnesium in a voltage-dependent 
manner (Nowak ct al., 1984). Several different modu- 
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latory sites on the NMDA receptor complex regulate 
channel activity. Glycine, acting at a strychnine-in- 
sensitive glycine binding site, enhances receptor acti- 
vation and is necessary for maximal activity (Johnson 
and Ascher, 1987; Kleckner and Dingledine, 1988). 
The dissociative anesthetics ketamine, phencyclidine 
(PCP), and (+)-5-methyl- 10, I l-dihydro-5H-dibenzo- 
[a,d]cyclohepten-5, lo-imine maleate (MK-80 1 ; di- 
zocilpine maleate) are noncompetitive antagonists of 
the NMDA receptor that bind to the so-called PCP 
site within the ion channel and prevent the passage of 
Na+ and Ca2+ through the channel (Anis et al., 1983; 
Honey et al., 1985; Reynolds et al., 1987; Wong et al., 
1987). Finally, Zn2+ and polyamines, acting at sepa- 
rate sites, also modulate NMDA receptor activity 
(Peters et al., 1987; Westbrook and Mayer, 1987; 
Ransom and Stec, 1988; Reynolds and Miller, 
1988a,b, 1989; Christine and Choi, 1990). 
Although NMDA receptors have been classified as 
a homogeneous population of receptors, some studies 
indicate the existence of subtypes of the NMDA re- 
ceptor (Perkins and Stone, 1983; Maragos et al., 1988; 
Monaghan et al., 1988; Honor6 et al., 1989; McDon- 
ald et al., 1990). Electrophysiological and radioligand 
binding studies indicate that one population of 
NMDA receptors, localized in the hindbrain and cere- 
bellum, is insensitive to quinolinate, whereas quino- 
h a t e  effectively depolarizes and potently displaces 
binding to forebrain NMDA receptors (Perkins and 
Stone, 1983; Stone and Burton, 1988; Monaghan and 
Beaton, 199 1). Receptor binding studies using ligands 
that label the PCP site have revealed low-affinity PCP 
binding sites in the cerebellum (Vignon et al., 1986; 
Ebert et al., 199 1). Throughout the forebrain the ratio 
of glycine to NMDA and PCP binding sites vanes 
between brain structures (McDonald et al., 1990). A 
striking example of variant stoichiometry among 
NMDA, PCP, and glycine binding sites is found in the 
cerebellar granule cell layer, where the density of 
NMDA and glycine binding sites is relatively high but 
that of PCP binding sites is low (Maragos et al., 1988; 
Young and Fagg, 1990). The presence of a unique 
NMDA receptor subtype in the cerebellum is sup- 
ported by the recent discovery of an NMDA receptor 
RNA that is localized specifically in the cerebellum 
and not in the forebrain (Kutsuwada et al., 1992; 
Monyer et al., 1992). 
Monaghan et al. (1988) have proposed the exis- 
tence of agonist- and antagonist-preferring forms of 
the NMDA receptor based on binding studies using 
[3H]glutamate and 3-(2-[3H]carboxypiperazin-4- 
y1)propyl- 1 -phosphonic acid (13H]CPP), an NMDA 
antagonist. Comparing agonist and antagonist dis- 
placement of ['Hlglutamate versus [3H]CPP in rat 
brain, these researchers reported that agonists are 
more potent inhibitors of [3H]glutamate binding than 
of [3H]CPP binding, whereas antagonists are more 
potent displacers of ['HICPP binding than of 13H]- 
glutamate binding. Furthermore, the relative propor- 
tions of agonist- and antagonist-preferring sites vaned 
across regions. 
Because binding of NMDA-receptor channel li- 
gands such as [3H]MK-80 1 is dependent on channel 
activation, [3H]MK-801 can be used not only as a 
label for NMDA receptors, but also as a marker for 
channel activation (Young and Fagg, 1990). To deter- 
mine if regional differences in NMDA receptor phar- 
macology exist in rat CNS, we have investigated the 
effects of differential activation of the NMDA recep- 




Male Sprague-Dawley rats (weighing 175-250 g; Charles 
River) were decapitated, and brains were removed rapidly, 
coated with Lipshaw embedding matrix, mounted on mi- 
crotome chucks, and frozen under powdered dry ice. Hori- 
zontal sections 20 pm thick were cut on a Lipshaw cryostat 
and thaw-mounted onto gelatin-coated slides. Sections were 
stored at -20°C for <24 h. 
Autoradiography 
A detailed description of the method for quantitative au- 
toradiography of [ 3H]MK-80 1 binding has been published 
(Sakurai et al., 1991). In brief, tissue sections were pre- 
washed in 50 mMTris-acetate buffer (pH 7.4) for 30 min at 
4°C and blown-dry under a stream of cool air before the 
[3H]MK-80 1 binding assay was performed. In all experi- 
ments, quadruplicate tissue sections were incubated for 2 or 
4 h in 50 mM Tris-acetate (pH 7.4) at room temperature 
containing 5 nM [3H]MK-801 at a final volume of 10 ml. 
Nonspecific binding was determined in the presence of 5 
~ k l  unlabeled MK-801. For control conditions in CPP 
competition studies, tissue sections were incubated with 
CPP in the presence of 1 pM glycine. In separate experi- 
ments assessing CPP inhibition of [3H]MK-80 1 binding 
under maximal stimulated conditions, glutamate (3 p M )  
was included in the incubation mixture containing CPP and 
1 pLM glycine. For control conditions in 7-chlorokynurenic 
acid (7-CIKyn) competition studies, tissue sections were in- 
cubated with 7-ClKyn in the presence of 3 pMglutamate. In 
separate experiments, glycine (1 p M )  was present in the 
incubation mixture containing 7-CIKyn and glutamate 
(3 N M ) .  
Following the incubation, sections were dipped quickly 
into 50 mM Tris-acetate buffer (pH 7.4) at 4"C, rinsed in 
250 ml of cold buffer for 80 min, and blown-dry under a 
stream of warm air. Dried tissue sections were placed in 
x-ray cassettes with appropriate radioactive standards and 
apposed to Hyperfilm (Amersham). Following a 3-4-week 
exposure period at 4"C, films were developed in D-19 (Ko- 
dak), fixed, and dried. All data presented were analyzed 
from resultant autoradiograms using computer-assisted 
image analysis (Imaging Research, Inc., St. Catharines, On- 
tario, Canada). Optical densities from autoradiograms were 
converted to binding densities using a polynomial regres- 
sion curve derived from the calibrated radioactive stan- 
dards. Ten to 20 readings per brain area from each of the 
quadruplicate sections were analyzed. Specific binding was 
calculated as the difference between total binding and non- 
specific binding. IC,, values for competitors of ['H]MK-80 1 
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binding were calculated by log-logit analysis. Apparent K, 
values for competitors of [3H]MK-80 1 binding were deter- 
mined by the method of Cheng and Prusoff (1973) using the 
formula K, = IC,,,/[ 1 + ([L]/K,)]. Previously established Kd 
values for [3H]MK-801 binding were used to determine ap- 
parent K, values in this study (Sakurai et al., 199 1). Because 
CPP and 7-ClKyn are known to act at sites distinct from the 
[3H]MK-801 binding site, the apparent K, values do not 
represent K, values for the competitors at the glutamate rec- 
ognition site or the glycine modulatory site but rather an 
estimate of the potency of these agents at interacting allo- 
sterically with the [3H]MK-80 1 binding site. The apparent 
K, values are mean f SEM values from four animals. Statis- 
tical comparison of regional apparent K, values was deter- 
mined by one-way analysis of variance (ANOVA), followed 
by Fisher's PLSD test for post hoc comparisons using the 
Statview 11 program (Abacus Concepts, Berkeley, CA, 
U.S.A.). Hill coefficients were compared by unpaired two- 
tailed Student's t test. 
Materials 
[3H]MK-80 1 was obtained from Dupont, NEN (Boston, 
MA, U.S.A.). Nonradioactive MK-801 was a gift from Dr. 
L. L. Iversen (Merck, Sharpe and Dohme Research Labora- 
tories, Essex, U.K.). CPP was purchased from Cambridge 
Research Biochemicals (Wilmington, DE, U.S.A.). 7- 
ClKyn was purchased from Tocris Neuramin (Essex). All 
other chemicals were purchased from Sigma (St. Louis, 
MO, U.S.A.). 
RESULTS 
CPP inhibition of [3H]MK-801 binding (2-h 
incubation) 
Under control conditions (no added glutamate, 1 
pMglycine), equilibrium was reached at 100 min and 
remained stable for up to 6 h. The addition of as much 
as 100 pM glutamate and 30 pM glycine did not in- 
crease binding above control conditions and did not 
accelerate association. Under control conditions, 
CPP inhibited ['HIMK-80 1 binding in a regionally 
distinct manner (Table 1). In cortical layers 1-111 
[outer cortex (OC)] and cortical layers IV-VI [medial 
cortex (MC)], [-'H]MK-80 1 binding was displaced 
with apparent K, values of 0.48 k 0.02 and 0.32 
k 0.02 pM(mean L SEM), respectively, and Hill coef- 
ficient (n,) values of 0.98 i 0.02 and 1.1 k 0.04, re- 
spectively. The apparent K, value of OC was signifi- 
cantly different from the K, value of MC under con- 
trol conditions ( p  < 0.02 by unpaired two-tailed 
Student's t test). Regional variation in CPP inhibition 
of [3H]MK-80 1 binding was observed in other brain 
areas. In medial striatum (MS), lateral striatum (LS), 
stratum radiatum of CA1 (CAI), and stratum mole- 
culare of dentate gyrus (DG) of hippocampus, appar- 
ent K, values ranged from 1.1 to 1.6 pM, and nH val- 
ues ranged from 0.9 1 to 1.0. [3H]MK-80 I binding was 
displaced in medial thalamus (MT) and lateral thala- 
mus (LT) with an apparent K, of 0.78 pMand an nH of 
1 .O t 0.1 and 1 .S L 0.12, respectively. The K, values 
for MS, LS, CA 1 , DG, MT, and LT were significantly 
different from those of OC and MC ( p  < 0.05 by AN- 
OVA and Fisher's PLSD). 
In the presence of added glutamate ( 3  p M ) ,  the CPP 
displacement curves for [3H]MK-80 1 binding shifted 
rightward (Fig. 1). The apparent K, values between 
regions maintained a similar relationship with the ex- 
ception of OC, where the apparent K, value increased 
2.5 times more than that in the other areas (Table 1). 
In the presence ofadded glutamate (3 pM),  CPP inhi- 
bition of [3H]MK-80 1 binding in MC (6.5 t_ 1.6 pM)  
TABLE 1. Regional variations in CPP inhibition of ["H]MK-80/ binding in rat brain 
Control Glutamate (3 p M )  
Region K, ( r W  nH K, (wW nH 
oc 0.48 t 0.02" 
MC 0.32 ? 0.02",d 
MS 1.56f0.11g 
LS 1.25 t 0.0Llh 
CA 1 I .42 f 0.07 
DG 1.10 +- 0.02' 
LT 0.78 f 0.09 

















23.9 f 1.7' 
6.51 f 1.68" 
34.0 f 1.1 
25.4 f 1.4 
22.3 t 2.01 
22.1 f 2.0 
14.5 f 0.57' 
14.6 t 0.53' 
1.9 2 0.19' 
1.3 k 0.23' 
1.9 t 0.05" 
1.9 t 0.12' 
1.8 t 0.12c 
1.8 c 0.12' 
1.9 +- 0.13' 
1.9 f 0.13' 
Apparent Ki values for each brain region were determined by quantitative autoradiography and 
are mean * SEM values from four animals. Differences in K, values between brain regions were 
significant at p < 0.05 by ANOVA and Fisher's PLSD as indicated. 
' Significantly different from MS, LS, CAI, DG, MT, and LT. 
' Significantly different from MC, LT, and MT. 
Significantly > I  ( p  < 0.0001 by Student's t test). 
Significantly different from OC, p < 0.02 by unpaired two-tailed Student's t test. 
'Significantly different from OC, MS, LS, CAI, DG, LT, and MT. 
'Significantly different from OC, p < 0.05 by unpaired two-tailed Student's t test. 
Significantly different from DG, LT, and MT. 
Significantly different from LT and MT. 
' Significantly different from LT and MT. 
Significantly different from MS, LS, CA 1, and DG. 
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FIG. 1. Inhibition of [3H]MK-801 binding by CPP (A) in outer corti- 
cal layers I - I l l  (OC) under control and stimulated conditions and (8) 
in cortical layers IV-VI (MC) under control and stimulated condi- 
tions. In control CPP displacement experiments (0), sections 
were incubated in the presence of added glycine (1 N). In CPP 
displacement studies under stimulated conditions (O), sections 
were incubated in the presence of added glycine (1 pM) and 
added glutamate (3 @). Data are mean + SEM (bars) values 
from four animals. 
was significantly more potent than in OC (23.9 f 1.1 
pM p < 0.05). The apparent Ki values for MS, LS, 
CAI, and DG ranged from 22 to 34 pM, whereas in 
MT and LT, CPP inhibited [3H]MK-80 1 binding 
with an apparent Ki of 14.5 pM. With glutamate stim- 
ulation, the nH values for CPP inhibition of [3H]MK- 
80 1 ranged from 1.3 to 1.9 and were significantly > 1 
( p  < 0.000 1). Figure 2 shows representative autoradio- 
grams depicting the anatomically distinct pattern of 
CPP displacement of [3H]MK-80 1 binding. 
CPP inhibition of [3H]MK-801 binding (4-h 
incubation) 
In addition to the standard 2-h incubation period, 
CPP inhibition of [3H]MK-80 1 binding under control 
conditions (presence of 1 pMglycine) and under stim- 
ulated conditions (presence of 1 pM glycine and 3 pLM 
glutamate) was examined using a 4-h incubation. 
CPP displacement curves for [3H]MK-80 1 binding fol- 
lowing a 4-h incubation were shifted (five- to eight- 
fold) to the right of CPP displacement curves obtained 
from 2-h incubations (Fig. 3). Under control condi- 
tions, the apparent Ki values between regions main- 
tained a similar relationship to apparent Ki values 
from 2-h incubations (Table 2). The apparent Ki val- 
ues for OC (3.8 k 0.3 pM)  and MC (2.0 f 0.4 p M )  
were significantly different from each other ( p  < 0.04 
by unpaired two-tailed Student’s t test). In MS, LS, 
CAI, and DG, the apparent K, values ranged from 5.8 
to 8.5 pM, whereas the apparent Ki values for LT and 
MT were 4. I and 4.3 pM, respectively. The apparent 
Ki values for MS, LS, CA 1, DG, LT, and MT differed 
significantly from those for OC and MC ( p  < 0.05 by 
ANOVA and Fisher’s PLSD). The Hill coefficients 
for CPP displacement of [3H]MK-801 ranged from 
1.1 to 1.6. 
Following a 4-h incubation in the presence of added 
glycine (1 pM) and glutamate (3 pM), CPP displace- 
ment curves for [3H]MK-80 1 binding were also 
shifted (two- to threefold) to the right of CPP curves 
obtained from 2-h incubations. CPP inhibited [3H]- 
MK-801 binding in OC with an apparent K, of 63.2 
k 3.65 pM. In MC, CPP was a more potent displacer 
of [3H]MK-801 binding, with an apparent Ki of 25.5 
t 0.85 pM. 
FIG. 2. Representative autoradiograms of 
[3H]MK-801 binding in horizontal rat brain 
sections. A: Total [3H]MK-801 binding. 6 
CPP (2 pM) inhibition of [3H]MK-801 bind- 
ing under stimulated conditions (in the pres- 
ence of 1 pM glycine and 3 glutamate). 
The arrow indicates cortical layers 1-111. 
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FIG. 3. Inhibition of [3H]MK-801 binding by CPP following a 2- or 
4-h incubation under control conditions (in the presence of 1 pbf 
glycine) in cortical layers 1-111 (OC). Data are mean +. SEM (bars) 
values from four animals. 
7-ClKyn inhibition of [3H]MK-SOl binding 
Inhibition of ['H]MK-80 1 binding by 7-ClKyn dis- 
tinguished a regionally distinct pattern of binding. 
Under control conditions, 7-ClKyn inhibited [3H]- 
MK-80 1 binding in OC, MC, MS, and LS with appar- 
ent Ki values of 6.3-8.6 pM, whereas in CA 1, DG, LT, 
and MT, significantly different apparent Ki values 
ranged from 1 1 to 13 p M ( p  < 0.05 by ANOVA; Fig. 4 
and Table 3). Hill coefficients ranged from 1.7 to 2.9 
and were all significantly > I  ( p  < 0.0001). 
In the presence of added glycine (1 pM) ,  the appar- 
ent Ki values for 7-ClKyn inhibition of [3H]MK-801 
binding shifted (five- to sixfold) in all brain regions 
with the exception of OC, which shifted by ninefold 
(Table 3). 7-ClKyn inhibited ['H]MK-80 1 binding in 
OC, CAI, and DG with apparent Ki values ranging 
from 70 to 75 gM. In MC, MS, and LS, the apparent 
Ki values of 30.0-48.0 pM differed significantly from 
OC, CA1, and DG ( p  < 0.05 by ANOVA and Fisher's 
PLSD), whereas in LT and MT the apparent Ki values 
were 60.2 k 2.6 and 56.4 k 1.6 pM, respectively. Hill 
coefficients ranging from 1.4 to 2.6, were significantly 
> 1 ( p  < 0.000 1 ). Figure 5 shows representative autora- 
diograms of 7-ClKyn inhibition of [3H]MK-80 1 bind- 
ing in rat brain. 
DISCUSSION 
To assess the distribution and modulation of the 
NMDA receptor channel, [3H]MK-80 I binding was 
used to label NMDA receptors in rat brain sections 
under conditions that differentially activated the re- 
ceptor. In well-washed homogenate preparations, 
[3H]MK-801 binding to the PCP site within the ion 
channel is highly regulated by glutamate and glycine, 
and the presence of both is necessary to measure bind- 
ing (Bonhaus and McNamara, 1988; Kloog et al., 
1988a,6; Javitt and Zukin, 1989a,b). NMDA and gly- 
cine antagonists, such as CPP and 7-C1Kyn, respec- 
tively, inhibit [.3H]MK-80 1 binding (Foster and 
Wong, 1987; Kloog et al., 1988a,b; Ransom and Stec, 
1988; Sircar et al., 1989; Sakurai et al., 199 1). Follow- 
ing our standard prewash, enough endogenous gluta- 
mate and glycine are present in the tissue sections to 
activate NMDA receptors and allow [3H]MK-80 1 to 
bind specifically (Sakurai et al., 1991). In this study, 
CPP inhibition of [3H]MK-80 1 binding was exam- 
ined under control conditions, that is, in the presence 
of a known amount of glycine, and under maximally 
stimulated conditions, that is, in the presence of both 
added glutamate and glycine. Similarly, 7-ClKyn inhi- 
bition of [3H]MK-80 1 binding was assessed under 
control conditions (presence of added glutamate) and 
under maximally stimulated conditions (presence of 
both added glutamate and added glycine). 
TABLE 2. Regional variations in CPP inhibition of['HJMK-801 binding in rat brain 
,following a 4-h incubation 
oc 3.76 f 0.27" I .3 f 0.05 63.3 -+ 3.6" 2.2 f 0.58' 
MC 2.03 2 0.45a*d I .  I 2 0.06 25.5 k 0.85 1.3 2 0.16 
8.51 -+ 1.1' 1.6k0.11 - - MS 
1.4 f 0.15 - - 8.34 k 1.1' LS 
7.42 f l . l g  1.3 k 0.13 - CA 1 
5.87 f O.4lg 1.1 f 0.09 Dc 
LT 4.17 +. 0.49 1.1 2 0.14 - 
M T  4.34 f 0.59 1.1 k 0.06 
Apparent Ki values for each brain region were determined by quantitative autoradiography and 
are mean ? SEM values from four animals. Differences in Ki values between brain regions were 
significant at p < 0.05 by ANOVA and Fisher's PLSD as indicated. 
Significantly different from MS, LS, CA 1, DG, MT, and LT. 
Significantly different from MC. 





' Significantly > 1 ( p  < 0.000 1 by Student's t test). 
' Significantly different from DG, LT, and MT. 
'Significantly different from DG, LT, and MT. 
Significantly different from LT and MT. 
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FIG. 4. Inhibition of r3H]MK-801 binding by 7-CIKyn in outer corti- 
cal layers 1-111 (OC) or stratum radiatum of hippocampus (CAI) 
under control conditions (presence of 3 pM glutamate). Data are 
mean f SEM (bars) values from four animals. 
Regionally distinct populations of NMDA recep- 
tors were distinguished on the basis of inhibition of 
[3H]MK-80 1 binding by CPP. Under control condi- 
tions the apparent Ki values for CPP inhibition of [3H]- 
MK-80 1 binding varied significantly across brain re- 
gions. CPP inhibited [3H]MK-80 1 binding most po- 
tently in OC and MC. In LT, MT, MS, LS, CA l ,  and 
DG, CPP inhibited [3H]MK-80 1 binding with signifi- 
cantly different affinities than in OC and MC. In the 
presence of glutamate (3 pM),  the potency of CPP to 
displace [3H]MK-80 1 binding maintained a similar 
rank order of differences between brain regions. A no- 
table difference, however, was the dramatic 50-fold 
rightward shift in the apparent Ki for CPP inhibition 
of [3H]MK-801 binding in OC. In other regions, the 
affinities changed by 20-fold. Furthermore, in the 
presence of glutamate, the apparent Ki for CPP inhibi- 
tion of [3H]MK-80 1 binding in OC was significantly 
greater than inhibition in MC but was now equipo- 
tent to that in LS, CAI, and DG. Based on direct 
labeling of the agonist and antagonist sites by [3H]- 
glutamate and [ 3H]CPP, respectively, Monaghan et 
al. (1988) demonstrated that MS consisted ofhigh lev- 
els of agonist-preferring sites, whereas LT and cortical 
layers contained higher levels of antagonist binding 
sites. The results of this study are consistent with these 
findings in that CPP inhibition of [3H]MK-80 1 bind- 
ing was most potent in LT/MT and in cortical layers 
and least potent in MS/LS. 
Monaghan (1 99 1) reported differential stimulation 
of [3H]MK-80 1 binding to NMDA receptors by L-glu- 
tamate in cortical layers as well as different brain re- 
gions. ['H]MK-80 1 binding was enhanced by low glu- 
tamate concentrations in the outer cortical layers (ago- 
nist-preferring NMDA receptors), whereas binding in 
the inner cortical layers was enhanced by high gluta- 
mate concentrations (antagonist-preferring NMDA 
receptors) (Monaghan, 199 1). In the present study in- 
hibition of [3H]MK-80 1 binding in OC and MC dis- 
played differential sensitivities to CPP under control 
conditions and in the presence of glutamate. Under 
control and maximally stimulated conditions, [3H]- 
MK-80 1 binding was more potently inhibited by CPP 
in the MC. These findings would be consistent with a 
predominance of antagonist-preferring NMDA re- 
ceptors in MC. Furthermore, Monaghan (1991) re- 
ported that MS was most sensitive to L-glutamate 
stimulation, suggesting that NMDA receptors in this 
area were agonist preferring. In the present study, [3H]- 
MK-801 binding in MS displayed the lowest affinity 
for CPP, suggesting the presence of the agonist-prefer- 
ring state of the NMDA receptor. 
Dansyz et al. (1989) demonstrated that agonist- and 
antagonist-preferring sites on the NMDA receptor 
TABLE 3. Regional variations in 7-ClKyn inhibition 










7.86 f 0.65" 
6.34 2 0.36" 
7.2 f 0.36" 
7.18 * 0.36" 
12.0 f 0.94 
12.53 & 0.81 
13.22 f 1.3 
1 1.42 f 0.87 
1.9 f 0.16' 
1.8 f 0.01 
2.2 t 0.08' 
1.8 f 0.13' 
2.2 f 0.26b 
1.7 f 0.14' 
2.6 t 0.36' 
2.9 k 0.29' 
Glycine (1 p M )  
Ki (wW nH 
70.1 k 4.5' 
30.0 I 1.9d 
48.0 k 3.4' 
38.2 t 2.6/ 
72.9 f 0.8Y 
75.0 f 3.1 a 
60.2 k 2.6 
56.4 +_ 1.6 
2.0 2 0.2 1 ' 
1.4 f 0.13b 
2.1 f 0.15' 
2.3 k 0.21' 
2.1 f 0.026 
2.2 f 0. 106 
2.6 f 0.15' 
2.4 t 0.03 
Apparent Ki values for each brain region were determined by quantitative autoradiography and 
are mean k SEM values from four animals. Differences in K, values between brain regions were 
significant at p < 0.05 by ANOVA and Fisher's PLSD as indicated. 
Significantly different from CAI, DG, MT, and LT. ' Significantly > 1 ( p  < 0.0001 by Student's t test). 
Significantly different from MC, MS, and LS. 
Significantly different from MS, LS, CAI, DG, LT, and MT. 
Significantly different from LS, CA 1, DG, LT, and MT. 
Significantly different from CA 1, DG, LT, and MT. 
Significantly different from MT and LT. 
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FIG. 5. Representative autoradiograms of [3H]MK-801 binding in horizontal rat brain sections. A: Total [3H]MK-801 binding. B: 7-CIKyn 
(10 p M )  inhibition of [3H]MK-801 binding under stimulated conditions (in the presence of 3 fiM glutamate and 1 pM glycine). C: 7-CIKyn (20 
pM) inhibition of [3H]MK-801 binding under stimulated conditions (in the presence of 3 p M  glutamate and 1 gM glycine). 
complex were independently regulated by glycine, 7- 
ClKyn, and HA-966. Furthermore, in homogenate 
studies, O'Shea et al. ( I  99 1) described regional hetero- 
geneity of the glycine binding site and three different 
mechanisms by which the glycine domain on the 
NMDA receptor may differentially modulate channel 
activity. The present study demonstrates that NMDA 
receptor populations can also be distinguished by reg- 
ulation at the strychnine-insensitive glycine binding 
site in an autoradiographic assay. 7-ClKyn inhibition 
of [3H]MK-80 1 binding distinguished regional differ- 
ences in NMDA receptor pharmacology that differed 
from the regional differences defined by CPP displace- 
ments. Under control conditions (no added glycine, 3 
puM glutamate), [3H]MK-801 binding in OC, MC, 
MS, and LS was inhibited by 7-ClKyn with similar 
potencies, whereas 7-ClKyn had a lower affinity for 
inhibiting [3H]MK-80 1 binding in LT, MT, DG, and 
CA 1. In the presence of added glycine, the apparent K, 
values for the regions shifted rightward, and addi- 
tional differences between regions became apparent. 
The potency of 7-ClKyn to inhibit [3H]MK-801 bind- 
ing in the MC was significantly greater than in OC in 
the presence of glycine, whereas in control conditions 
the affinities were similar. Unlike the dramatic in- 
creases in apparent K, values obtained for CPP inhibi- 
tion of t3H]MK-801 binding in the presence of added 
glutamate, the increases in the apparent K, values for 
7-ClKyn inhibition in the presence of glycine were 
only five- to ninefold across brain areas. The present 
study demonstrates regionally distinct regulation of 
[3H]MK-80 I binding by the NMDA agonist site and 
the strychnine-insensitive glycine binding site. 
The presence of glutamate and glycine enhances 
NMDA receptor activity and increases the association 
rate of [3H]MK-80 1, but CPP slows the rate of associa- 
tion (Kloog et al., 1988a,b). We have demonstrated 
previously that in our autoradiographic assay [3H]- 
MK-80 1 binding is at equilibrium by 2 h (Sakurai et 
al., 1991). In the displacement assays performed in 
this study, however, at high concentrations of CPP the 
association rate of [3H]MK-80 1 binding may have 
been slowed enough such that binding was at nonequi- 
librium conditions. Furthermore, regional differences 
in endogenous glutamate concentrations could also 
cause apparent regional differences in K, values for 
CPP inhibition of [3H]MK-80 1 binding. To address 
these issues, CPF inhibition of [3H]MK-80 1 binding 
was examined following a 4-h incubation period 
under control conditions (presence of 1 pM glycine) 
and under stimulated conditions (presence of 1 pLM 
glycine and 3 pM glutamate). 
Following a 4-h incubation period, under control 
conditions (presence of 1 pMglycine) the apparent K, 
values increased in all brain regions examined. The 
differences between apparent K, values for the various 
regions following a 4-h incubation, however, main- 
tained a similar relationship in comparison to the ap- 
parent K, values obtained after a 2-h incubation. As 
the rank order of differences in apparent K, values 
between regions was maintained at the longer incuba- 
tion period, this suggests that the differences in appar- 
ent K, values between regions were not due to the 
presence of varying amounts of endogenous gluta- 
mate in the tissue. Because the apparent K, values for 
CPP inhibition of [3H]MK-80 1 binding did increase 
following a 4-h incubation, it appears that in the pres- 
ence of CPP [3H]MK-80 1 binding may be at nonequi- 
librium conditions. As the rank order of regional dif- 
ferences in apparent K, values was maintained at the 
longer incubation period, the regional differences in 
apparent K, values are probably due to differential 
activation of the NMDA receptor-ion channel com- 
plex between regions. Even if binding was not at equi- 
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librium, the results of this study suggest that [3H]MK- 
80 1 binding can be used to demonstrate regional het- 
erogeneity of binding under conditions of differential 
activation. Nonequilibrium binding of another PCP 
ligand, N-( 1 -[2-thienyl]cy~lohexy1)-3,4-[~H]piperidine, 
([3H]TCP) has also been shown to be a reliable marker 
of the activated state of the NMDA receptor complex 
(Hosford et al., 1990). 
Glutamate and glycine antagonists may slow the 
association rate of [3H]MK-80 1 binding and thereby 
artificially result in high Hill coefficients (Sakurai et 
al., 1991). In the present study under control condi- 
tions, the apparent Hill coefficients were not signifi- 
cantly different than 1 for CPP inhibition of [3H]MK- 
801 binding. The presence of glycine (1 wLM) in the 
control condition for CPP inhibition of [3H]MK-80 1 
binding may have been sufficient enough to allow 
equilibrium to be reached even at the highest CPP 
concentrations. In the presence of glutamate, how- 
ever, the Hill coefficients for CPP inhibition of [3H]- 
MK-80 1 binding were significantly > 1. Because 
higher concentrations of CPP were required to inhibit 
[3H]MK-80 I binding in the presence of glutamate, 
association rates at the higher concentrations of CPP 
may have been slowed, thereby artificially raising the 
Hill coefficients. Even after 4-h incubations, however, 
the Hill coefficients in the presence of glutamate were 
> 1. The Hill coefficients for 7-ClKyn inhibition of 
[3H]MK-80 1 binding were significantly > 1 under 
both control and stimulated conditions. These high 
Hill coefficients may also reflect the effect of antago- 
nists on the association rate for [3H]MK-80 1 binding. 
Alternatively, the presence of added glutamate and 
glycine may reveal more than one population of bind- 
ing sites, which would also be reflected in Hill coeffi- 
cients of > 1. The allosteric interaction between sites 
also may be altered under conditions that differen- 
tially activate the NMDA receptor complex, thereby 
resulting in higher Hill coefficients. 
On the basis of our study, it appears that regional 
heterogeneity of NMDA receptor pharmacology can 
be demonstrated by NMDA agonist site and strych- 
nine-insensitive glycine binding site regulation of 
[3H]MK-80 1 binding in rat forebrain. One popula- 
tion of NMDA receptors, distributed in the MC, ex- 
hibited a higher affinity for CPP than in the outer 
cortical layers. Another population of NMDA recep- 
tor subtypes in MT and LT had a slightly lower affin- 
ity for CPP, whereas NMDA receptors distributed in 
the MS and LS as well as in the DG and CA 1 region of 
the hippocampus exhibited the lowest affinity for 
CPP. Regulation of the NMDA receptor complex at 
the strychnine-insensitive glycine binding site re- 
vealed the presence of at least two populations of 
NMDA receptors. One population of receptors, dis- 
tributed in the OC and MC and the LS and MS, had a 
higher affinity for the glycine antagonist 7-ClKyn 
than NMDA receptors distributed in the MT and LT 
and the DG and CAI region of the hippocampus. 
The results of our study suggest that the regional 
heterogeneity of [3H]MK-80 1 binding in rat forebrain 
under certain conditions may be due to the presence 
of at least two or more subtypes of the NMDA recep- 
tors that are differentially regulated by the glutamate 
and glycine binding sites. Alternatively, two or three 
receptor subtypes may be expressed in different pro- 
portions within a region, resulting in heterogeneity of 
[3H]MK-80 1 binding under any given conditions. 
Our study focused on the forebrain because under our 
standard assay conditions, [3H]MK-80 1 binding is 
not present in the cerebellum (Sakurai et al., 1991). 
Electrophysiological and binding studies suggest, how- 
ever, that a pharmacologically distinct NMDA recep- 
tor is present in the cerebellum (Perkins and Stone, 
1983; Stone and Burton, 1988; Monaghan and Bea- 
ton, 1991). 
The heterogeneity of [3H]MK-80 1 binding under 
conditions that differentially activate the NMDA re- 
ceptor in the forebrain may be due to the regionally 
specific expression of different NMDA receptor pro- 
teins. Now that the NMDA receptor has been cloned 
(Kumaretal., 1991;Moriyoshietal., 1991), character- 
ization of the heterogeneity of the NMDA receptor at 
the molecular level will be possible. In fact, Nakanishi 
and co-workers have reported discrepancies between 
the distribution of NMDA receptor ligand binding 
sites and NMDA receptor mRNA expression sites, 
which may reflect the presence of multiple NMDA 
receptor subtypes (Moriyoshi et al., 199 1). More re- 
cently, three additional NMDA receptor subunits 
have been cloned (Meguro et al., 1992; Monyer et al., 
1992). These subunits are expressed selectively 
throughout the brain, and different combinations of 
these subunits exhibit functional diversity when char- 
acterized electrophysiologically (Meguro et al., 1992; 
Monyer et al., 1992). The molecular diversity of the 
NMDA receptor subunits and the posttranslational 
processing of receptor proteins are likely to contribute 
to the pharmacological heterogeneity of the NMDA 
receptor complex. 
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